The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides.
retrieved 8 November 2023 from https://medicalxpress.com/news/2023-11-fda-hospitalizations-linked-counterfeit-ozempic.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Nov 7, 2023 Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
RHOBH’s Erika Jayne Answers Ozempic Claims: ‘It’s Really Not Anybody’s Business’The RHOBH star has been accused by her co-star of using the weight loss drug. Read more on Grazia.
Lire la suite »
Ozempic Can’t Fix America’s Obesity CrisisA box of Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that makes Ozempic, has reported record quarterly results, up nearly 3% on the stock market. The company's revenues rose by 38% to DKK 58.73 billion, some 7.8 billion euros.
Lire la suite »
FDA approves Voquezna for erosive esophagitis, GERDThe U.S. Food and Drug Administration has approved Phathom Pharmaceuticals' Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of erosive esophagitis or erosive gastroesophageal reflux disease (GERD).
Lire la suite »
Food banks see tens of thousands of first-time users as parcels hit record highThe Trussell Trust said 320,000 people have needed to use a food bank for the first time in the past six months.
Lire la suite »
Shortage of food safety workers ‘leaving consumers and businesses vulnerable’The number of UK food standards officers has fallen by 45% compared with 10 years ago, according to a report by food safety watchdogs.
Lire la suite »
Food banks see tens of thousands of first-time users as parcels hit record highThe Trussell Trust said 320,000 people have needed to use a food bank for the first time in the past six months.
Lire la suite »